Tibor Hlavatý

4.7k total citations
58 papers, 1.3k citations indexed

About

Tibor Hlavatý is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Tibor Hlavatý has authored 58 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Genetics, 32 papers in Epidemiology and 16 papers in Surgery. Recurrent topics in Tibor Hlavatý's work include Inflammatory Bowel Disease (30 papers), Microscopic Colitis (25 papers) and Biosimilars and Bioanalytical Methods (6 papers). Tibor Hlavatý is often cited by papers focused on Inflammatory Bowel Disease (30 papers), Microscopic Colitis (25 papers) and Biosimilars and Bioanalytical Methods (6 papers). Tibor Hlavatý collaborates with scholars based in Slovakia, Belgium and United States. Tibor Hlavatý's co-authors include Séverine Vermeire, T. Köller, Marc Ferrante, M Huorka, Juraj Payer, Gert Van Assche, Maja Noman, Paul Rutgeerts, Philippe Persoons and Liesbet Henckaerts and has published in prestigious journals such as Gastroenterology, Scientific Reports and The American Journal of Gastroenterology.

In The Last Decade

Tibor Hlavatý

55 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tibor Hlavatý Slovakia 17 702 652 331 200 144 58 1.3k
Marc Schwartz United States 23 1.0k 1.5× 853 1.3× 459 1.4× 153 0.8× 92 0.6× 76 1.5k
Ignacio Marín‐Jiménez Spain 22 871 1.2× 734 1.1× 373 1.1× 337 1.7× 125 0.9× 124 1.5k
Michael Trummler Switzerland 11 1.0k 1.4× 861 1.3× 577 1.7× 199 1.0× 123 0.9× 12 1.4k
Arun Swaminath United States 16 667 1.0× 532 0.8× 475 1.4× 389 1.9× 107 0.7× 82 1.3k
Tran M Nguyen Canada 23 952 1.4× 722 1.1× 420 1.3× 180 0.9× 119 0.8× 64 1.6k
Matteo Rosselli Italy 18 766 1.1× 1.3k 1.9× 526 1.6× 165 0.8× 68 0.5× 35 1.8k
Carla Felice Italy 19 739 1.1× 573 0.9× 257 0.8× 360 1.8× 208 1.4× 80 1.6k
Oren Ledder Israel 20 724 1.0× 474 0.7× 484 1.5× 168 0.8× 171 1.2× 72 1.3k
Marco Gasparetto United Kingdom 16 564 0.8× 328 0.5× 307 0.9× 182 0.9× 227 1.6× 49 1.0k
Zoltán Szepes Hungary 20 541 0.8× 425 0.7× 565 1.7× 286 1.4× 144 1.0× 143 1.3k

Countries citing papers authored by Tibor Hlavatý

Since Specialization
Citations

This map shows the geographic impact of Tibor Hlavatý's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tibor Hlavatý with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tibor Hlavatý more than expected).

Fields of papers citing papers by Tibor Hlavatý

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tibor Hlavatý. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tibor Hlavatý. The network helps show where Tibor Hlavatý may publish in the future.

Co-authorship network of co-authors of Tibor Hlavatý

This figure shows the co-authorship network connecting the top 25 collaborators of Tibor Hlavatý. A scholar is included among the top collaborators of Tibor Hlavatý based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tibor Hlavatý. Tibor Hlavatý is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hlavatý, Tibor, et al.. (2020). Novel unorthodox strategies to reduce the case fatality rate of COVID-19 in high risk groups. Bratislavské lekárske listy/Bratislava medical journal. 121(7). 462–465. 3 indexed citations
2.
Šoltýs, Katarína, Tibor Hlavatý, Jaroslav Budiš, et al.. (2020). Seasonal changes of circulating 25-hydroxyvitamin D correlate with the lower gut microbiome composition in inflammatory bowel disease patients. Scientific Reports. 10(1). 6024–6024. 29 indexed citations
3.
Kužma, Martin, Tibor Hlavatý, Didier Hans, et al.. (2017). Decrease of trabecular bone score reflects severity of Crohn’s disease: results of a case–control study. European Journal of Gastroenterology & Hepatology. 30(1). 101–106. 5 indexed citations
4.
Köller, T., et al.. (2017). Drug-induced liver injury in inflammatory bowel disease: 1-year prospective observational study. World Journal of Gastroenterology. 23(22). 4102–4102. 35 indexed citations
5.
Hlavatý, Tibor, et al.. (2016). Relapse rates of inflammatory bowel disease patients in deep and clinical remission after discontinuing anti-tumor necrosis factor alpha therapy. Bratislavské lekárske listy/Bratislava medical journal. 116(4). 205–211. 6 indexed citations
6.
Hlavatý, Tibor. (2014). Higher vitamin D serum concentration increases health related quality of life in patients with inflammatory bowel diseases. World Journal of Gastroenterology. 20(42). 15787–15787. 50 indexed citations
7.
Hlavatý, Tibor, et al.. (2013). Smoking, breastfeeding, physical inactivity, contact with animals, and size of the family influence the risk of inflammatory bowel disease: A Slovak case–control study. United European Gastroenterology Journal. 1(2). 109–119. 51 indexed citations
8.
Hlavatý, Tibor, M Bátovský, Peter Celec, et al.. (2013). The impact of thiopurine-S-methyltransferase genotype on the adverse drug reactions to azathioprine in patients with inflammatory bowel diseases. Bratislavské lekárske listy/Bratislava medical journal. 114(4). 199–205. 10 indexed citations
9.
Köller, T., et al.. (2010). [Prevalence of liver disease markers among patients with metabolic risk factors].. PubMed. 56(3). 183–9. 6 indexed citations
10.
Mesquita, Mirjam Bueno de, Marc Ferrante, Liesbet Henckaerts, et al.. (2008). Clustering of (auto)immune diseases with early-onset and complicated inflammatory bowel disease. European Journal of Pediatrics. 168(5). 575–583. 8 indexed citations
11.
Hlavatý, Tibor, Philippe Persoons, Séverine Vermeire, et al.. (2006). Evaluation of short-term responsiveness and cutoff values of inflammatory bowel disease questionnaire in Crohnʼs disease. Inflammatory Bowel Diseases. 12(3). 199–204. 75 indexed citations
12.
Hlavatý, Tibor, et al.. (2006). Predictive Model for the Outcome of Infliximab Therapy in Crohnʼs Disease Based on Apoptotic Pharmacogenetic Index and Clinical Predictors. Inflammatory Bowel Diseases. 13(4). 372–379. 59 indexed citations
13.
Ugorcakova, Jana, Tibor Hlavatý, Pavel Babál, et al.. (2006). Assay design and optimization of mutant-enriched PCR based method for detection of K-ras gene mutations in pancreatic carcinoma.. PubMed. 53(5). 363–71. 3 indexed citations
14.
Hlavatý, Tibor, Philippe Persoons, Séverine Vermeire, et al.. (2005). IBDQ score is a sensitive instrument to assess short-term changes in disease related quality of life in patients with luminal Crohn's disease. Gastroenterology. 128(4).
15.
Vermeire, Séverine, Marieke Pierik, Liesbet Henckaerts, et al.. (2005). Study on DLG5 and OCTN polymorphisms shows association of the OCTN to risk haplotype with perianal and fistulizing Crohn's disease but not with susceptibility to IBD. Gastroenterology. 128(4). 2 indexed citations
16.
Hlavatý, Tibor, Marc Ferrante, Liesbet Henckaerts, et al.. (2005). Prediction of response to infliximab in luminal and fistulizing Crohn's disease based on a decision making model using an apoptotic pharmacogenetic index and clinical predictors. Gastroenterology. 128(4). 1 indexed citations
17.
Henckaerts, Liesbet, Marie Joossens, Tibor Hlavatý, et al.. (2005). Study on CARD15 and TLR4 polymorphisms in children with early diagnosed IBD and their family members. Gastroenterology. 128(4). 1 indexed citations
18.
Ferrante, Marc, Liesbet Henckaerts, Tibor Hlavatý, et al.. (2005). Vascular endothelial growth factor (VEGF) polymorphisms are implicated in susceptibility to IBD. Gastroenterology. 128(4). 1 indexed citations
19.
Hlavatý, Tibor, et al.. (2005). Positive family history promotes participation in colorectal cancer screening.. PubMed. 106(10). 318–23. 10 indexed citations
20.
Hlavatý, Tibor, Liesbet Henckaerts, Marc Ferrante, et al.. (2005). Polymorphisms in apoptosis genes predict response to infliximab therapy in luminal and fistulizing Crohn's disease. Alimentary Pharmacology & Therapeutics. 22(7). 613–626. 153 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marc Schwartz Breakdown of academic impact, for papers by Ignacio Marín‐Jiménez Breakdown of academic impact, for papers by Michael Trummler Breakdown of academic impact, for papers by Arun Swaminath Breakdown of academic impact, for papers by Tran M Nguyen Breakdown of academic impact, for papers by Matteo Rosselli Breakdown of academic impact, for papers by Carla Felice Breakdown of academic impact, for papers by Oren Ledder Breakdown of academic impact, for papers by Marco Gasparetto Breakdown of academic impact, for papers by Zoltán Szepes
Rankless by CCL
2026